The collaboration will focus on developing a localized and sustained-release drug delivery system for oncology patients
Vigabatrin for Oral Solution USP, 500 mg had annual sales of USD 233.7 mn in the United States
AstraZeneca and Merck are committed to working with the FDA to bring LYNPARZA in combination with abi/pred to patients diagnosed with mCRPC.
Julian Collins, Jana Windt and Michiel Stork join biopharma company’s leadership team
With digitally available health records, individuals can avail paper-less health services under Ayushman Bharat Digital Mission (ABDM)
The portfolio includes approximately 45 commercial products, four pipeline products and 40 approved non-marketed products, including a number of generic products focused on women’s health.
Natco launched pomalidomide under their brand NAT-POMALIDOMIDE in strengths of 1 mg, 2 mg, 3 mg and 4 mg capsules
Amala Hospital partners with LifeSigns to provide revolutionary technology for the first time in the State
The company expects the GMP approval from Saudi Food and Drug Authority (SFDA) to soon pave the way for marketing authorizations from the largest market in the GCC region
Receives Subject Expert Committee recommendation to bring new therapies of Pompe, ASMD to India
Subscribe To Our Newsletter & Stay Updated
